Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02747147 · ClinicalTrials.gov registry record · NA
Multi-Day Evaluation of the TIVA Device
A NA study of Blood Collections Via Peripheral IV Catheter, sponsored by Velano Vascular.
- Completed
- Registry status
- NA
- Development phase
- 160
- Enrollment target
- 1
- Study location
NCT02747147: Completed NA study of Blood Collections Via Peripheral IV Catheter, sponsored by Velano Vascular.
NCT02747147 is a NA study of Blood Collections Via Peripheral IV Catheter that has completed, run by Velano Vascular. The registered enrollment target is 160 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (89% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02747147, a NA study of Blood Collections Via Peripheral IV Catheter, has completed, sponsored by Velano Vascular.
- COMPLETED
- Registry status
- NA
- Development phase
- 160 participants
- Enrollment target
- 1
- Study location
Study Summary
Prospective, randomized, single-center study to evaluate the ability of the device to collect good quality blood samples from patients with peripheral IV access over the length of their stay.
Primary Outcome
blood aspiration with the device is attempted once per day. The % of attempts that are successful will be reported across all attempts
Conditions Studied
Interventions
- DEVICE TIVA blood collection device
Study Locations (1)
Massachusetts
- Brigham and Women's Hospital - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 160 participants |
| Start Date | 2016-04-12 |
| Est. Completion | 2016-12-07 |
| Phase | NA |
What the finished NCT02747147 record still lists
NCT02747147 is an interventional study that assigns participants to a tested intervention. The registered 160 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (89% lower).
The record links to 1 condition, with Blood Collections Via Peripheral IV Catheter appearing as the primary indexed condition, and to 1 intervention - of which TIVA blood collection device is the first listed.
NCT02747147 reports a single indexed study location in Massachusetts.
Frequently Asked Questions
What is clinical trial NCT02747147 about?
NCT02747147 is a clinical study titled "Multi-Day Evaluation of the TIVA Device". Prospective, randomized, single-center study to evaluate the ability of the device to collect good quality blood samples from patients with peripheral IV access over the length of their stay.
What is the current status of trial NCT02747147?
This trial is currently completed. It is a NA study. The enrollment target is 160 participants. The study started on 2016-04-12. Estimated completion is 2016-12-07.
What conditions does trial NCT02747147 study?
This clinical trial studies the following conditions: Blood Collections Via Peripheral IV Catheter.
What interventions are being tested in trial NCT02747147?
The interventions under investigation include: TIVA blood collection device (DEVICE).
Who is sponsoring clinical trial NCT02747147?
This trial is sponsored by Velano Vascular, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02747147 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02747147's enrollment target sits among peer trials
160 628th of 2000 higher than 1,347 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00501826 · 160 participants · Phase 2
Combination Chemotherapy and Nelarabine in Treating Patients With T-cell Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma
- NCT00932139 · 160 participants · NA
Effect of Electro-Acupuncture on Blood Pressure
- NCT00992901 · 160 participants · Early Phase 1
Role of Neural and Hormonal Regulation Factors on Insulin Secretion After Gastric Bypass Surgery
- NCT01515527 · 160 participants · Phase 2
Cladribine Plus Low Dose Cytarabine (LDAC) Alternating With Decitabine in Patients With Acute Myeloid Leukemia (AML) or High-Risk Myelodysplastic Syndrome (MDS)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI